Discounted Cash Flow Rating
Buy
Return on Equity Rating
Neutral
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Neutral
Analyst Rating
Neutral
Simple Moving Average
Strong Sell
Exponential Moving Average
Strong Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Buy
Wall Street Data Solutions Rating
Neutral
B
USANA Health Sciences Inc (USNA)
Medicinal Chemicals & Botanical Products
http://www.usanahealthsciences.com
Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.
3838 WEST PARKWAY BLVD.
SALT LAKE CITY, UT
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/22/1993
Market Cap
750,660,620
Shares Outstanding
19,130,000
Weighted SO
19,129,806
Total Employees
N/A
Upcoming Earnings
07/23/2024
Beta
0.8970
Last Div
0.0000
Range
37.35-65.27
Chg
0.2600
Avg Vol
80008
Mkt Cap
750660620
Exch
NYSE
Country
US
Phone
801 954 7100
DCF Diff
-29.7352
DCF
69.1452
Div Yield
0.0000
P/S
0.8578
EV Multiple
4.2846
P/FV
1.4671
Div Yield %
0.0000
P/E
13.6429
PEG
-1.6936
Payout
0.0000
Current Ratio
4.0337
Quick Ratio
3.4385
Cash Ratio
3.1996
DSO
0.0000
DIO
131.1652
Op Cycle
131.1652
DPO
14.1025
CCC
117.0627
Gross Margin
0.8034
Op Margin
0.0964
Pretax Margin
0.1079
Net Margin
0.0629
Eff Tax Rate
0.4169
ROA
0.0872
ROE
0.1113
ROCE
0.1599
NI/EBT
0.5831
EBT/EBIT
1.1200
EBIT/Rev
0.0964
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
446.2381
CF/Debt
0.0000
Equity Multi
1.2327
Rec Turnover
0.0000
Pay Turnover
25.8819
Inv Turnover
2.7828
FA Turnover
8.9585
Asset Turnover
1.3860
OCF/Share
3.8762
FCF/Share
3.1081
Cash/Share
17.4290
OCF/Sales
0.0845
FCF/OCF
0.8018
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
5.0464
Div&CapEx Cov
5.0464
P/BV
1.4671
P/B
1.4671
P/S
0.8578
P/E
13.6429
P/FCF
12.6630
P/OCF
10.1647
P/CF
10.1647
PEG
-1.6936
P/S
0.8578
EV Multiple
4.2846
P/FV
1.4671
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
22.31K Shares Bought (38.64 %)
35.43K Shares Sold (61.36%)
3 - 6 Months
209.00K Shares Bought (69.84 %)
90.26K Shares Sold (30.16%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 299.02M | ▼ 271.30M | ▲ 310.52M | ▼ 267.30M | ▼ 227.96M | ▼ 221.08M | ▲ 227.80M |
Cost Of Revenue | 49.47M | ▼ 47.29M | ▲ 59.02M | ▼ 52.52M | ▼ 46.43M | ▼ 42.32M | ▲ 43.07M |
Gross Profit | 249.56M | ▼ 224.01M | ▲ 251.50M | ▼ 214.78M | ▼ 181.53M | ▼ 178.76M | ▲ 184.73M |
Gross Profit Ratio | 0.83 | ▼ 0.83 | ▼ 0.81 | ▼ 0.80 | ▼ 0.80 | ▲ 0.81 | ▲ 0.81 |
Research And Development Expenses | 10.24M | ▲ 10.26M | ▲ 10.63M | ▲ 11.11M | ▲ 11.56M | ▼ 11.45M | ▼ 0.00 |
General And Administrative Expenses | 68.28M | ▼ 65.06M | ▲ 69.17M | ▼ 68.59M | ▼ 61.10M | ▼ 58.66M | ▲ 64.30M |
Selling And Marketing Expenses | 132.71M | ▼ 114.38M | ▲ 129.79M | ▼ 114.69M | ▼ 97.88M | ▼ 95.88M | ▼ 95.76M |
Selling General And Administrative Expenses | 200.99M | ▼ 179.44M | ▲ 198.96M | ▼ 183.28M | ▼ 158.98M | ▼ 154.55M | ▲ 160.06M |
Other Expenses | 895.00K | ▲ 1.23M | ▲ 1.99M | ▼ 141.00K | ▲ 251.00K | ▼ -368.00K | ▲ -186.00K |
Operating Expenses | 200.99M | ▼ 179.44M | ▲ 198.96M | ▼ 183.28M | ▼ 158.98M | ▼ 154.55M | ▲ 160.06M |
Cost And Expenses | 250.46M | ▼ 226.73M | ▲ 257.98M | ▼ 235.79M | ▼ 205.41M | ▼ 196.86M | ▲ 203.13M |
Interest Income | 1.29M | ▼ 956.00K | ▼ 656.00K | ▼ 589.00K | ▲ 1.46M | ▲ 2.91M | ▼ 2.68M |
Interest Expense | 9.00K | ▲ 22.00K | ▼ -1.11M | ▲ 18.00K | ▲ 32.00K | ▲ 145.00K | ▼ 52.00K |
Depreciation And Amortization | 4.11M | ▲ 5.73M | ▼ 5.52M | ▲ 5.66M | ▼ 5.25M | ▼ -1.00 | ▲ 5.08M |
Ebitda | 48.57M | ▼ 44.57M | ▲ 52.54M | ▼ 31.51M | ▼ 22.55M | ▲ 24.22M | ▲ 32.25M |
Ebitda Ratio | 0.16 | ▲ 0.16 | ▲ 0.17 | ▼ 0.12 | ▼ 0.10 | ▲ 0.11 | ▲ 0.14 |
Operating Income | 48.57M | ▼ 44.57M | ▲ 52.54M | ▼ 31.51M | ▼ 17.30M | ▲ 24.22M | ▲ 24.67M |
Operating Income Ratio | 0.16 | ▲ 0.16 | ▲ 0.17 | ▼ 0.12 | ▼ 0.08 | ▲ 0.11 | ▼ 0.11 |
Total Other Income Expenses Net | 895.00K | ▲ 1.23M | ▲ 1.99M | ▼ 141.00K | ▲ 5.50M | ▼ 2.39M | ▲ 2.44M |
Income Before Tax | 49.46M | ▼ 45.80M | ▲ 54.53M | ▼ 31.65M | ▼ 22.80M | ▲ 26.61M | ▲ 27.11M |
Income Before Tax Ratio | 0.17 | ▲ 0.17 | ▲ 0.18 | ▼ 0.12 | ▼ 0.10 | ▲ 0.12 | ▼ 0.12 |
Income Tax Expense | 17.13M | ▼ 15.05M | ▼ 14.90M | ▼ 11.33M | ▼ 10.01M | ▼ 9.85M | ▲ 10.57M |
Net Income | 32.33M | ▼ 30.75M | ▲ 39.63M | ▼ 20.32M | ▼ 12.80M | ▲ 16.77M | ▼ 16.54M |
Net Income Ratio | 0.11 | ▲ 0.11 | ▲ 0.13 | ▼ 0.08 | ▼ 0.06 | ▲ 0.08 | ▼ 0.07 |
Eps | 1.37 | ▲ 1.42 | ▲ 1.88 | ▼ 1.04 | ▼ 0.67 | ▲ 0.88 | ▼ 0.86 |
Eps Diluted | 1.32 | ▲ 1.41 | ▲ 1.87 | ▼ 1.03 | ▼ 0.66 | ▲ 0.87 | ▼ 0.86 |
Weighted Average Shs Out | 23.57M | ▼ 21.66M | ▼ 21.04M | ▼ 19.39M | ▼ 19.21M | ▼ 19.13M | ▲ 19.17M |
Weighted Average Shs Out Dil | 24.46M | ▼ 21.75M | ▼ 21.19M | ▼ 19.67M | ▼ 19.26M | ▼ 19.25M | ▲ 19.30M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 214.33M | ▲ 234.83M | ▲ 311.92M | ▼ 239.83M | ▲ 288.42M | ▲ 330.42M | ▼ 328.34M |
Short Term Investments | 63.54M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 277.87M | ▼ 234.83M | ▲ 311.92M | ▼ 239.83M | ▲ 288.42M | ▲ 330.42M | ▼ 328.34M |
Net Receivables | 14.03M | ▼ 8.76M | ▼ 7.42M | ▼ 7.16M | ▲ 7.21M | ▼ 7.20M | ▼ 1.00 |
Inventory | 81.95M | ▼ 68.91M | ▲ 90.22M | ▲ 98.32M | ▼ 67.09M | ▼ 61.45M | ▼ 60.87M |
Other Current Assets | 32.52M | ▼ 25.54M | ▼ 23.15M | ▲ 26.97M | ▲ 28.87M | ▼ 17.49M | ▲ 31.86M |
Total Current Assets | 392.34M | ▼ 329.28M | ▲ 425.29M | ▼ 365.12M | ▲ 384.38M | ▲ 416.57M | ▲ 421.07M |
Property Plant Equipment Net | 92.03M | ▲ 95.23M | ▲ 100.45M | ▲ 101.78M | ▼ 97.77M | ▲ 117.49M | ▼ 98.19M |
Goodwill | 16.82M | ▼ 16.64M | ▲ 17.37M | ▲ 17.67M | ▼ 17.37M | ▼ 17.10M | ▼ 16.90M |
Intangible Assets | 31.81M | ▼ 29.84M | ▲ 30.80M | ▼ 30.44M | ▲ 32.43M | ▼ 29.92M | ▼ 29.11M |
Goodwill And Intangible Assets | 48.63M | ▼ 46.48M | ▲ 48.16M | ▼ 48.11M | ▲ 49.80M | ▼ 47.02M | ▼ 46.01M |
Long Term Investments | 0.00 | 0.00 | ▲ 20.00M | ▲ 23.82M | ▼ 2.90M | ▼ 2.83M | ▼ -1.00 |
Tax Assets | 3.35M | ▼ 3.09M | ▲ 4.64M | ▲ 4.84M | ▲ 9.80M | ▲ 13.28M | ▼ 11.35M |
Other Non Current Assets | 18.13M | ▲ 42.86M | ▼ 42.35M | ▼ 34.07M | ▲ 51.90M | ▼ 35.58M | ▲ 52.67M |
Total Non Current Assets | 162.13M | ▲ 187.66M | ▲ 215.60M | ▼ 212.62M | ▼ 212.17M | ▲ 216.19M | ▼ 208.20M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 |
Total Assets | 554.46M | ▼ 516.93M | ▲ 640.89M | ▼ 577.74M | ▲ 596.55M | ▲ 632.76M | ▼ 629.28M |
Account Payables | 9.95M | ▲ 12.53M | ▲ 18.20M | ▼ 13.51M | ▼ 11.05M | ▼ 10.07M | ▼ 8.27M |
Short Term Debt | -15.06M | ▲ 8.32M | ▲ 8.62M | ▼ 7.08M | ▼ 6.89M | ▲ 8.06M | ▼ 1.32M |
Tax Payables | 20.77M | ▼ 16.53M | ▲ 20.27M | ▼ 16.52M | ▼ 16.21M | ▼ 3.30M | ▼ 0.00 |
Deferred Revenue | 15.06M | ▼ 13.85M | ▲ 15.95M | ▲ 19.64M | ▲ 20.88M | ▼ 13.91M | ▼ 0.00 |
Other Current Liabilities | 138.74M | ▼ 101.40M | ▲ 125.31M | ▼ 120.57M | ▼ 105.02M | ▼ 86.80M | ▲ 103.05M |
Total Current Liabilities | 148.69M | ▼ 136.10M | ▲ 168.07M | ▼ 160.79M | ▼ 143.83M | ▼ 118.85M | ▼ 112.63M |
Long Term Debt | 0.00 | ▲ 17.27M | ▼ 12.86M | ▼ 10.22M | ▼ 7.68M | ▼ 5.14M | ▼ 0.00 |
Deferred Revenue Non Current | 0.00 | ▼ -17.27M | ▲ -12.86M | ▲ -10.22M | ▲ -7.68M | ▲ -5.14M | ▲ 0.00 |
Deferred Tax Liabilities Non Current | 13.37M | ▼ 10.28M | ▲ 12.01M | ▼ 7.50M | ▼ 4.07M | ▲ 4.55M | ▲ 5.11M |
Other Non Current Liabilities | 1.26M | ▲ 1.57M | ▲ 6.30M | ▼ 4.11M | ▲ 14.17M | ▼ 12.16M | ▼ 11.54M |
Total Non Current Liabilities | 14.63M | ▲ 29.12M | ▲ 31.16M | ▼ 21.83M | ▼ 18.24M | ▼ 16.71M | ▼ 16.66M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Lease Obligations | 0.00 | ▲ 8.32M | ▲ 8.62M | ▼ 7.08M | ▼ 6.89M | ▼ 5.14M | ▼ 0.00 |
Total Liabilities | 163.32M | ▲ 165.22M | ▲ 199.24M | ▼ 182.62M | ▼ 162.08M | ▼ 135.56M | ▼ 129.29M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 499.97M |
Common Stock | 24.00K | ▼ 22.00K | ▼ 21.00K | ▼ 19.00K | 19.00K | 19.00K | 19.00K |
Retained Earnings | 329.50M | ▼ 306.15M | ▲ 382.79M | ▼ 344.64M | ▲ 391.64M | ▲ 445.22M | ▲ 453.45M |
Accumulated Other Comprehensive Income Loss | -10.39M | ▼ -13.90M | ▲ -3.63M | ▲ 458.00K | ▼ -12.79M | ▼ -13.70M | ▼ -18.59M |
Other Total Stockholders Equity | 72.01M | ▼ 59.45M | ▲ 62.46M | ▼ 50.01M | ▲ 55.60M | ▲ 65.66M | ▼ -434.86M |
Total Stockholders Equity | 391.15M | ▼ 351.71M | ▲ 441.65M | ▼ 395.12M | ▲ 434.47M | ▲ 497.20M | ▲ 499.99M |
Total Equity | 391.15M | ▼ 351.71M | ▲ 441.65M | ▼ 395.12M | ▲ 434.47M | ▲ 497.20M | ▲ 499.99M |
Total Liabilities And Stockholders Equity | 554.46M | ▼ 516.93M | ▲ 640.89M | ▼ 577.74M | ▲ 596.55M | ▲ 632.76M | ▼ 629.28M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 554.46M | ▼ 516.93M | ▲ 640.89M | ▼ 577.74M | ▲ 596.55M | ▲ 632.76M | ▼ 629.28M |
Total Investments | 63.54M | ▼ 0.00 | ▲ 20.00M | ▲ 23.82M | ▼ 2.90M | ▼ 2.83M | ▼ -1.00 |
Total Debt | 0.00 | ▲ 8.32M | ▲ 8.62M | ▼ 7.08M | ▼ 6.89M | ▲ 13.21M | ▼ 1.32M |
Net Debt | -214.33M | ▼ -226.51M | ▼ -303.30M | ▲ -232.75M | ▼ -281.53M | ▼ -317.22M | ▼ -327.02M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | 32.33M | ▼ 30.75M | ▲ 39.63M | ▼ 20.32M | ▼ 12.80M | ▲ 16.77M | ▼ 16.54M |
Depreciation And Amortization | 4.11M | ▲ 5.73M | ▼ 5.52M | ▲ 5.66M | ▼ 5.25M | ▼ 4.87M | ▲ 5.08M |
Deferred Income Tax | 4.22M | ▲ 7.00M | ▼ 2.20M | ▼ -367.00K | ▲ 1.13M | ▲ 1.47M | ▲ 2.55M |
Stock Based Compensation | 3.93M | ▼ 2.86M | ▲ 3.88M | ▼ 3.26M | ▲ 3.52M | ▲ 3.64M | ▲ 3.67M |
Change In Working Capital | -4.17M | ▲ 9.36M | ▼ -3.86M | ▼ -3.97M | ▲ 17.77M | ▼ -3.33M | ▼ -11.49M |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | -1.16M | ▲ 9.13M | ▼ -7.93M | ▲ -1.89M | ▲ 7.64M | ▼ -1.05M | ▼ -1.80M |
Accounts Payables | -4.58M | ▲ 3.08M | ▲ 3.90M | ▼ -349.00K | ▲ 86.00K | ▲ 1.93M | ▼ -1.72M |
Other Working Capital | 1.57M | ▼ -2.85M | ▲ 167.00K | ▼ -1.73M | ▲ 10.04M | ▼ -4.20M | ▼ -7.97M |
Other Non Cash Items | 1.00K | ▲ 47.00K | ▲ 556.00K | ▼ 16.00K | ▼ 3.00K | ▲ 2.60M | ▼ -16.54M |
Net Cash Provided By Operating Activities | 40.43M | ▲ 55.74M | ▼ 47.92M | ▼ 24.92M | ▲ 40.46M | ▼ 26.02M | ▼ 17.68M |
Investments In Property Plant And Equipment | -2.57M | ▼ -5.20M | ▲ -1.48M | ▼ -3.15M | ▼ -3.29M | ▼ -7.32M | ▲ -3.20M |
Acquisitions Net | 0.00 | ▲ 61.89M | ▼ 0.00 | 0.00 | ▲ 3.00K | ▼ 2.00K | ▲ 3.00K |
Purchases Of Investments | -4.72M | ▲ 1.66M | ▼ -20.00M | ▲ 1.56M | ▼ 0.00 | ▲ 5.06M | ▼ -870.00K |
Sales Maturities Of Investments | 22.86M | ▼ -63.54M | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 48.00K | ▲ 86.00K | ▼ 51.00K | ▼ -1.56M | ▲ 3.00K | ▼ 2.00K | ▼ -867.00K |
Net Cash Used For Investing Activities | 15.61M | ▼ -5.11M | ▼ -21.43M | ▲ -3.15M | ▼ -3.28M | ▼ -7.32M | ▲ -4.07M |
Debt Repayment | 0.00 | ▼ -5.00M | ▼ -60.00M | ▲ 0.00 | ▼ -500.00K | ▼ -792.00K | ▲ -537.00K |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Repurchased | -79.79M | ▲ -305.00K | ▼ -426.00K | ▼ -31.91M | ▲ -150.00K | ▲ -134.00K | ▼ -9.44M |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -433.00K | ▲ 4.70M | ▲ 59.53M | ▼ -534.00K | ▲ 500.00K | ▲ 1.45M | ▼ -3.04M |
Net Cash Used Provided By Financing Activities | -80.22M | ▲ -305.00K | ▼ -472.00K | ▼ -32.45M | ▲ -150.00K | ▲ 658.00K | ▼ -11.95M |
Effect Of Forex Changes On Cash | -1.36M | ▲ 1.80M | ▲ 8.58M | ▼ 2.44M | ▲ 3.93M | ▲ 4.06M | ▼ -3.81M |
Net Change In Cash | -25.54M | ▲ 52.13M | ▼ 34.59M | ▼ -8.24M | ▲ 40.96M | ▼ 23.34M | ▼ -2.14M |
Cash At End Of Period | 217.23M | ▲ 237.69M | ▲ 315.94M | ▼ 243.65M | ▲ 291.32M | ▲ 330.42M | ▲ 331.11M |
Cash At Beginning Of Period | 242.77M | ▼ 185.56M | ▲ 281.35M | ▼ 251.89M | ▼ 250.36M | ▲ 307.08M | ▲ 333.25M |
Operating Cash Flow | 40.43M | ▲ 55.74M | ▼ 47.92M | ▼ 24.92M | ▲ 40.46M | ▼ 26.02M | ▼ 17.68M |
Capital Expenditure | -2.57M | ▼ -5.20M | ▲ -1.48M | ▼ -3.15M | ▼ -3.29M | ▼ -7.32M | ▲ -3.20M |
Free Cash Flow | 37.86M | ▲ 50.54M | ▼ 46.43M | ▼ 21.77M | ▲ 37.18M | ▼ 18.70M | ▼ 14.48M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)